Ehab A M El-Shoura

20PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safetyEnvironmental epidemiologyPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 03, 2026
Ivabradine alleviates the cisplatin-induced cardiotoxicity in rats through regulating the crosstalk between MLCP/PKG, MEK/ERK pathways and miRNA-34a levels.

|Jul 31, 2026
Effects of tadalafil on endothelial, angiogenic, metabolic, and microRNA biomarker profiles in sexually active men with BPH and erectile dysfunction: a randomized controlled trial.

|Jun 24, 2026
Ebastine mitigates cisplatin-induced pulmonary injury associated with alterations in the miR-101/PI3K/mTOR/ULK1 signaling axis.

|Apr 20, 2026
Naftidrofuryl Exerts Neuroprotective Effects in a Rotenone-Induced Rat Model of Parkinson's Disease Through Modulation of PINK1/Parkin and ER Stress Pathways.

|Feb 04, 2026
Telmisartan and nicorandil attenuate Polymyxin B-induced renal injury by modulating NrF2/NQO1, FAS/FASL signaling, and mitigation of P53, Cyt-C, and caspase-3.

Heba M Mahmoud, Omnia A M Abd El-Ghafar, Ehab A M El-Shoura

|Jan 26, 2026
Obeticholic Acid and Methyl Ferulic Acid Mitigate Arsenic Trioxide-Induced Hepatotoxicity by Targeting Profibrotic and Proinflammatory Signaling.

Souty M Z Sharkawi, Elshaimaa A Arafa, Ehab A M El-Shoura

Pageof 4

Frequent Collaborators

2 joint publications

Dalia Zafaar

1 joint publications

Basim A S Messiha

1 joint publications

Mohamed S Refaey

1 joint publications

Mohamed E Abouelela